Hikma Pharmaceutical | HIK - Gross Profit On Sales

Stock Price
1,234.50
Daily Change
-50.50 -3.93%
Monthly
-24.40%
Yearly
-38.95%
Q1 Forecast
1,214.21

Hikma Pharmaceutical reported $362.5M in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Almirall EUR 429.87M 180.02M Dec/2025
argenx SE USD 1.14B 118.49M Dec/2025
AstraZeneca USD 12.39B 5M Dec/2025
Autolus Therapeutics Ltd USD -7.45M 3.93M Sep/2025
Bayer EUR 5.35B 1.02B Sep/2025
Fresenius EUR 1.51B 214M Dec/2025
Galapagos EUR -13.57M 74.82M Sep/2025
Genmab DKK 868M 195M Jun/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 2.96B 252M Dec/2025
Orion EUR 508.7M 254.5M Dec/2025
Recordati EUR 432.41M 8.56M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
UCB EUR 2.46B 520M Dec/2024